Abetalipoproteinemia
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
dietary treatment + vitamin/mineral supplementation
The treatment goal for all patients is to maximize caloric intake and prevent the sequelae of neuromuscular deterioration that results from fat-soluble vitamin deficiency, specifically from vitamin E (alpha-tocopherol).[1]Shapiro MD, Feingold KR. Monogenic disorders causing hypobetalipoproteinemia. In: Feingold KR, Anawalt B, Boyce A, et al. eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000–2021. https://www.ncbi.nlm.nih.gov/books/NBK326744 [2]Lee J, Hegele RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis. 2014 May;37(3):333-9. http://www.ncbi.nlm.nih.gov/pubmed/24288038?tool=bestpractice.com [7]Burnett JR, Bell DA, Hooper AJ, et al. Clinical utility gene card for: abetalipoproteinaemia--update 2014. Eur J Hum Genet. 2015 Jun;23(6). https://www.doi.org/10.1038/ejhg.2014.224 http://www.ncbi.nlm.nih.gov/pubmed/25335492?tool=bestpractice.com
In addition to vitamin and mineral supplements, the patient should begin a low-fat diet consisting of <20% fat from total calories (5-20 g fat per day). If fat is ingested, medium-chain triglycerides are least toxic. However, limitation of any fats is most favorable. A diet containing essential fatty acids, found in safflower oil, is recommended. No significant complications arise from this intervention.
Vitamin D (cholecalciferol) can be given, but this is not critical because it can also be activated on the skin by ultraviolet rays from endogenously produced metabolites; hence, requirements in adults seem to be satisfied by nondietary sources. However, a supplement can be given to individuals of all ages and incurs no risk of toxicity, thus no need for monitoring.
Iron, folate, or vitamin B12 (cyanocobalamin) supplementation may be necessary to reverse signs of anemia.[29]Takahashi M, Okazaki H, Ohashi K, et al. Current diagnosis and management of abetalipoproteinemia. J Atheroscler Thromb. 2021 Oct 1;28(10):1009-19. https://www.doi.org/10.5551/jat.RV17056 http://www.ncbi.nlm.nih.gov/pubmed/33994405?tool=bestpractice.com Folic acid can be given, though evidence for or against supplementation is lacking. It can be taken indefinitely as it is nontoxic.
Primary options
alpha-tocopherol (vitamin E): 100-300 international units/kg/day orally
OR
vitamin A (retinol): 100-400 international units/kg/day orally
OR
phytonadione (vitamin K1): 5-35 mg/week orally
OR
cholecalciferol (vitamin D3): 800-1200 international units/day orally
OR
ferrous sulfate: 50-100 mg orally three times daily
OR
folic acid (vitamin B9): 0.4 to 1 mg orally once daily
OR
cyanocobalamin (vitamin B12): 1000 micrograms subcutaneously/intramuscularly once daily for 1 week, followed by 1000 micrograms once weekly for 1 month, then 1000 micrograms once monthly thereafter
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer